Do sodium-glucose cotransporter-2 inhibitors affect renal hemodynamics by different mechanisms in type 1 and type 2

Petter Bjornstad1, Robert G Nelson2, Meda E Pavkov3

  • 1Section of Endocrinology, Department of Pediatrics, Division of Nephrology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.

Kidney International
|January 6, 2020
PubMed

Insights

Sodium-glucose cotransporter-2 inhibitors protect kidneys in type 2 diabetes by reducing hyperfiltration. This effect in older adults may involve post-glomerular vasodilation, differing from mechanisms in younger patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Sodium-glucose cotransporter-2 inhibitors (SGLT2i) show nephroprotective effects in type 2 diabetes (T2D).
  • Hyperfiltration attenuation is a proposed mechanism for SGLT2i-induced nephroprotection.
  • In type 1 diabetes, afferent arteriolar vasoconstriction via tubuloglomerular feedback is implicated in young adults.

Purpose of the Study:

  • To investigate the mechanism of glomerular filtration rate (GFR) attenuation by SGLT2i in older adults with T2D.
  • To determine if the mechanism observed in type 1 diabetes applies to older adults with T2D.

Main Methods:

  • The study by van Bommel et al. examined hemodynamic changes in the glomerulus.
  • Analysis focused on the role of afferent versus efferent arteriolar tone.

Main Results:

  • Older adults with T2D undergoing SGLT2i treatment showed attenuation of elevated GFR.
  • This attenuation was achieved through post-glomerular vasodilation, not afferent arteriolar vasoconstriction.
  • The findings suggest a different nephroprotective mechanism in this population compared to younger individuals with type 1 diabetes.

Conclusions:

  • The mechanism of SGLT2i-mediated nephroprotection in older adults with T2D differs from that observed in younger individuals with type 1 diabetes.
  • Post-glomerular vasodilation appears to be the key factor in attenuating hyperfiltration in this specific demographic.
  • These findings have implications for understanding and optimizing SGLT2i therapy in diverse patient groups.

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
539
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
529
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
136.3K